1Malet-Martino M, Jolimaitre P, Martino R. The prodngs of 5-flu- orouracil [ J ]. Curr Med Chem Anticaneer Agents,2002,2 ( 2 ) :267- 310.
2Liss R H, Chadwick M. Correlation of 5-fluorouracil ( NSC-19893 ) distribution in rodents with toxicity and chemotherapy in man[ J ]. Cancer Chemother Rep, 1 974,58 (6) : 777-786.
3Andersson M, Domellof L, Haggmark S,et al. Cardiopulmonary he- modynarnics and pharmacokinetics 'after hepatic intraarterial infu- sion of 5-fluomuracil (5-FU). An experimental study in the pig [ J ]. Cancer Chemother Pharmacol, 1988,22 ( 3 ) :251-255.
5Bertolini A, Fiuman O M, Muffatti A, et al. Acute cardiotoxicity from 5-fluorouracil : an underestimated toxicity [ J ], Minerva Car- dioangiol, 1999,47 (7/8) :269-273.
6Casciato D A, Lowitz B B. Manual of clinical oncology [ M ]. 4th ed. Amacian : Lippincott Williams & Wilkins ,2003:66-67.
7Prunier F,Monsegu J,Coutant G,et al. Emergency coronary angio- plasty following treatment with 5-fluorouracil [ J ].Rev Med Interne, 2000,21 (5) :439-444.
8Yokoyama T, Hosoya Y, Aoki T, et al. Angian attact caused by 5-fluorouracil infusion-report of a case and review of the literature [ J]. Can To Kagaku Ryoho,2002,29 (10) :1805-1808.
9Gaveau T, Banzet P, Marneffe H, et al. Cardiovascular disorders in the course of antimitotic infusions at high doses. 30 clinical cases [ J ]. Anesth Analg ( Paris ), 1969,26 ( 3 ) : 311-327.
10Dent R G, McColl I. Letter :5-fluorouracil and angina [ J ]. Lancet, 1975 ,1 (7902) :347-348.
